Answer
Patients with hepatic metastasis or pre-existing advanced hepatic impairment may be at increased risk of liver toxicity due to radiation exposure during treatment with Lutathera (lutetium (177Lu) oxodotreotide).
Sources for this answer
- Lutathera 370 MBq/mL solution for infusionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked